Although activating mutations of the TKR RET are believed to be the primary oncogenic event in the development of a majority of MTC cases, it is clear that RET cooperates with other signal transduction pathways to promote MTC tumorigenesis. The gene discussed is TKTL1; the disease is medullary thyroid gland carcinoma.